Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer

NCT01807156 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT01807156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01807156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2013
Completion date
February 28, 2015
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular cancer